ÍøºìºÚÁÏ

This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after…

Investigator

Brian Stover

Status

Accepting Candidates

Ages

180 Days - 22 Years

Sexes

All

This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune…

Investigator

Brian Stover

Status

Accepting Candidates

Ages

N/A - 21 Years

Sexes

All

This phase II trial tests the safety and best dose of revumenib in combination with chemotherapy, and evaluates whether this treatment improves the outcome in infants and young children who have leukemia that has come back (relapsed) or does not…

Investigators

Brian Stover, William Slayton

Status

Accepting Candidates

Ages

1 Month - 6 Years

Sexes

All